Veloxis Pharmaceuticals logo
Healthcare & Life Sciences

Veloxis Pharmaceuticals

United Stateswww.veloxis.com/

Veloxis Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
1
Investors

About Veloxis Pharmaceuticals

Based in the United States, Veloxis Pharmaceuticals is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Veloxis Pharmaceuticals develops specialty pharmaceutical therapies focused on transplant and immunocompromised patients, aiming to improve outcomes in transplant medicine. It operates as a subsidiary of Asahi Kasei Corporation, advancing treatments for transplant care and immunosuppression.

Explore Veloxis Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States